|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.89 USD | -5.63% |
|
-24.36% | -6.75% |
| 14/05 | Transcript : Curis, Inc. - Special Call | |
| 14/05 | Curis, Inc. Announces Additional Data from Take Aim Leukemia Study | CI |
Curis, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was USD 2.3 million compared to USD 2.06 million a year ago. Net loss was USD 11.56 million compared to USD 16.11 million a year ago.
Basic loss per share from continuing operations was USD 2.4 compared to USD 3.6 a year ago. Diluted loss per share from continuing operations was USD 2.4 compared to USD 3.6 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -6.75% | 7.43Cr | |
| +34.09% | 5.08TCr | |
| +0.59% | 4.28TCr | |
| +49.62% | 4.2TCr | |
| -4.96% | 2.95TCr | |
| +10.81% | 2.61TCr | |
| -21.69% | 1.91TCr | |
| +8.94% | 1.31TCr | |
| +26.68% | 1.22TCr | |
| +24.12% | 1.21TCr |
CURIS, INC. 